Donald Young - Sumitomo Dainippon Independent Director

DPM Stock  EUR 2.34  0.10  4.46%   

Director

Mr. Donald W. Young FCPA, FCA, is an Independent Director of Dundee Precious Metals Inc. Mr. Young, FCPA, FCA has served as Chair of the Audit Committee since 2013. Mr. Young is a retired KPMG audit partner. For a number of years, he also worked as a KPMG management consulting partner focused on operational and organization reviews, governance, and controlrisk management. Before joining KPMG, he worked for Placer Development Ltd. . He currently serves on the board and chairs the audit committee of Midas Gold Corporationration He has served on the boards and chaired audit committees of other publiclylisted mining companies and served on the governing boards of notforprofit organizations, including Science World British Columbia, British Columbia Safety Authority and the Canadian Institute of Chartered Accountants. Mr. Young is a Fellow and past President of the British Columbia Chartered Accountants and is a member of the Institute of Corporationrationrate Directors. since 2010.
Age 71
Tenure 14 years
Phone81 6 6203 5321
Webhttps://www.sumitomo-pharma.com

Donald Young Latest Insider Activity

Tracking and analyzing the buying and selling activities of Donald Young against Sumitomo Dainippon stock is an integral part of due diligence when investing in Sumitomo Dainippon. Donald Young insider activity provides valuable insight into whether Sumitomo Dainippon is net buyers or sellers over its current business cycle. Note, Sumitomo Dainippon insiders must abide by specific rules, including filing SEC forms every time they buy or sell Sumitomo Dainippon'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Sumitomo Dainippon Management Efficiency

Sumitomo Dainippon's management efficiency ratios could be used to measure how well Sumitomo Dainippon manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 243.96 B in total debt with debt to equity ratio (D/E) of 6.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sumitomo Dainippon Pharma has a current ratio of 1.85, which is within standard range for the sector. Debt can assist Sumitomo Dainippon until it has trouble settling it off, either with new capital or with free cash flow. So, Sumitomo Dainippon's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sumitomo Dainippon Pharma sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sumitomo to invest in growth at high rates of return. When we think about Sumitomo Dainippon's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Randall FindlaySuperior Plus Corp
67
Robert EngbloomSuperior Plus Corp
64
Maciej KrywoniukBANK HANDLOWY
N/A
Walentin MiroshSuperior Plus Corp
71
Patrick GottschalkSuperior Plus Corp
54
Peter KernNorAm Drilling AS
50
Richard BradeenSuperior Plus Corp
61
Craig JacobsonNorAm Drilling AS
65
Laura WalkerNorAm Drilling AS
60
Michael KregerNorAm Drilling AS
33
Catherine BestSuperior Plus Corp
64
Ross LevinsohnNorAm Drilling AS
54
Peter MurphyNorAm Drilling AS
55
Douglas HarrisonSuperior Plus Corp
58
Katarzyna OtkoDabrowskaBANK HANDLOWY
N/A
David SmithSuperior Plus Corp
59
Mary JordanSuperior Plus Corp
58
James ArestiaNorAm Drilling AS
N/A
Eugene BissellSuperior Plus Corp
64
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients and additives, veterinary medicines, diagnostics, and others. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. SUMITOMO DAINIPPON operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6140 people. Sumitomo Dainippon Pharma (DPM) is traded on Frankfurt Exchange in Germany and employs 6,987 people.

Management Performance

Sumitomo Dainippon Pharma Leadership Team

Elected by the shareholders, the Sumitomo Dainippon's board of directors comprises two types of representatives: Sumitomo Dainippon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sumitomo. The board's role is to monitor Sumitomo Dainippon's management team and ensure that shareholders' interests are well served. Sumitomo Dainippon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sumitomo Dainippon's outside directors are responsible for providing unbiased perspectives on the board's policies.
Peter Nixon, Independent Director
Richard Gosse, Vice President - Exploration
Theophile Yameogo, Vice President - Digital Innovation
Colin McAnuff, Treasurer
Takuya Taguchi, Sr Unit
Kelly StarkAnderson, Vice President - Legal and Corporate Secretary
Hideyuki Harada, Mfg Div
Richard Howes, COO, Executive Vice President
Garth MacRae, Independent Director
Hiroyuki Baba, Legal Design
Toru Kimura, Regenerative Strategy
Zebra Kasete, Vice President and Managing Director of Dundee Precious Metals Tsumeb
Donald Young, Independent Director
Lori Beak, Senior Vice President - Investor & Regulatory Affairs,Corporate Secretary
Jeremy Kinsman, Independent Director
Brent Johnson, Vice President - Environment
Paul Proulx, Senior Vice President - Corporate Services
Nikolay Hristov, Senior Vice President - Sustainable Business Development
Hratch Jabrayan, Vice President General Manager - Dundee Precious Metals Kapan CJSC
Jonathan Goodman, President CEO, Non-Independent Director
Yoshiharu Ikeda, Modality Cancer
John Lindsay, Senior Vice President - Projects
Mark Crawley, Vice President - Commercial Affairs
Peter Gillin, Lead Independent Director
MarieAnne Tawil, Director
Naoki Noguchi, Corp Governance
Hisayoshi Kashima, Sr Controller
Hume Kyle, CFO, Executive Vice President
Anthony Walsh, Independent Director
Juanita Montalvo, Director
David Rae, Senior Vice President - Operations
Hiroshi Nomura, Pres CEO
Michael Dorfman, Senior Vice President - Corporate Development
Atsuko Higuchi, Corp Affairs
Shigeyuki Nishinaka, Sr Director
Murray John, Independent Director

Sumitomo Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sumitomo Dainippon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sumitomo Dainippon in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sumitomo Dainippon's short interest history, or implied volatility extrapolated from Sumitomo Dainippon options trading.

Pair Trading with Sumitomo Dainippon

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sumitomo Dainippon position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sumitomo Dainippon will appreciate offsetting losses from the drop in the long position's value.

Moving together with Sumitomo Stock

  0.89EII EisaiPairCorr

Moving against Sumitomo Stock

  0.88E908 Lyxor 1 -PairCorr
  0.87RDDA Dr Reddys LaboratoriesPairCorr
  0.84TEV Teva PharmaceuticalPairCorr
  0.84PQ9 BANK MANDIRIPairCorr
  0.83MBG Mercedes-Benz GroupPairCorr
The ability to find closely correlated positions to Sumitomo Dainippon could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sumitomo Dainippon when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sumitomo Dainippon - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sumitomo Dainippon Pharma to buy it.
The correlation of Sumitomo Dainippon is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sumitomo Dainippon moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sumitomo Dainippon Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sumitomo Dainippon can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Sumitomo Dainippon Pharma. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Sumitomo Stock analysis

When running Sumitomo Dainippon's price analysis, check to measure Sumitomo Dainippon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sumitomo Dainippon is operating at the current time. Most of Sumitomo Dainippon's value examination focuses on studying past and present price action to predict the probability of Sumitomo Dainippon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sumitomo Dainippon's price. Additionally, you may evaluate how the addition of Sumitomo Dainippon to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Global Correlations
Find global opportunities by holding instruments from different markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Please note, there is a significant difference between Sumitomo Dainippon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sumitomo Dainippon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sumitomo Dainippon's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.